Delivery Order SPE2DB22D3009-SPE2DB25FBE65
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,370.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This non-set-aside, competitively awarded contract is scheduled for completion by July 21, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,012.91 on August 8, 2025, for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product for joint pain management. This is a firm fixed price contract with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The delivery order is scheduled for completion by August 11, 2025, with performance based in...
- The Defense Logistics Agency awarded a $1,729.05 delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This firm fixed price contract, issued on July 29, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order specifies a place of performance in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6mL, a hyaluronic acid-based joint injection used for osteoarthritis treatment. This competitively awarded, non-set-aside contract was finalized on August 18, 2025, with a ceiling value of $4,087.80 and a firm fixed price structure. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for knee osteoarthritis treatment. This firm fixed-price delivery order, valued at $3,246.60, was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $15,725.21. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Synvisc-One is a viscosupplementation injection used for osteoarthritis...
- The Defense Logistics Agency awarded a delivery order valued at $11,568.32 to AmerisourceBergen Drug Corp for Synvisc-One syringes (6mL) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Synvisc-One is a hyaluronic acid-based injectable used for knee osteoarthritis treatment, indicating this procurement...
- The Defense Logistics Agency awarded a $3,624 delivery order to Amerisourcebergen Drug Corporation for SYNVISC-ONE SYRINGE 6ML under a firm fixed price contract. Performance will take place in Conshohocken, Pennsylvania from July 18-19, 2023. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to the Department of Defense. As a top pharmaceutical supplier, Amerisourcebergen will deliver the requested...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBE65Delivery Order
The Defense Logistics Agency awarded a $7,898.36 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Synvisc-One syringes (6mL), with completion targeted for September 9, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle extending through December 2026 that supports global military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company maintains extensive capability to deliver pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Synvisc-One—a hyaluronic acid injection used for osteoarthritis treatment—exemplifies the company's role in supplying brand-name medical products to support Defense Health Agency and other government healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 9/8/25 |